SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$331.67

Market cap

$126.35B

P/E Ratio

37.48

Dividend/share

$3.15

EPS

$8.85

Enterprise value

$136.88B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
Stryker's EPS has increased by 28% YoY and by 6% from the previous quarter
SYK's net income is up by 28% year-on-year and by 6% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
380.95M
Market cap
$126.35B
Enterprise value
$136.88B
Valuations
Price to earnings (P/E)
37.48
Price to book (P/B)
6.58
Price to sales (P/S)
6.02
EV/EBIT
34.95
EV/EBITDA
31.68
EV/Sales
6.53
Earnings
Revenue
$20.96B
EBIT
$3.92B
EBITDA
$4.32B
Free cash flow
$2.86B
Per share
EPS
$8.85
Free cash flow per share
$7.51
Book value per share
$50.42
Revenue per share
$55.11
TBVPS
$51.37
Balance sheet
Total assets
$39.4B
Total liabilities
$20.23B
Debt
$12.87B
Equity
$19.17B
Working capital
$4.94B
Liquidity
Debt to equity
0.67
Current ratio
1.71
Quick ratio
0.85
Net debt/EBITDA
2.44
Margins
EBITDA margin
20.6%
Gross margin
63.8%
Net margin
16%
Operating margin
19.7%
Efficiency
Return on assets
8.7%
Return on equity
18.4%
Return on invested capital
17.6%
Return on capital employed
12.1%
Return on sales
18.7%
Dividend
Dividend yield
0.95%
DPS
$3.15
Payout ratio
35.6%

SYK stock price

How has the Stryker stock price performed over time
Intraday
1.29%
1 week
-2.72%
1 month
-2.6%
1 year
14.32%
YTD
10.76%
QTD
-2.52%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$20.96B
Gross profit
$13.38B
Operating income
$4.13B
Net income
$3.36B
Gross margin
63.8%
Net margin
16%
The operating income has grown by 32% year-on-year and by 6% since the previous quarter
SYK's net income is up by 28% year-on-year and by 6% since the previous quarter
Stryker's operating margin has increased by 19% YoY and by 3.7% QoQ
SYK's net margin is up by 15% YoY and by 3.9% from the previous quarter

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
37.48
P/B
6.58
P/S
6.02
EV/EBIT
34.95
EV/EBITDA
31.68
EV/Sales
6.53
Stryker's EPS has increased by 28% YoY and by 6% from the previous quarter
SYK's P/E is 13% below its 5-year quarterly average of 42.4 and 7% below its last 4 quarters average of 39.8
SYK's equity is up by 13% year-on-year and by 3.1% since the previous quarter
SYK's P/B is 4.7% above its 5-year quarterly average of 6.2
The company's revenue rose by 11% YoY and by 2.3% QoQ
The stock's price to sales (P/S) is 8% more than its 5-year quarterly average of 5.5 and 2.4% more than its last 4 quarters average of 5.8

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has increased by 34% YoY and by 6% from the previous quarter
The ROA has grown by 21% YoY and by 4.8% from the previous quarter
Stryker's ROS has increased by 19% YoY and by 4.5% from the previous quarter
The ROE rose by 15% YoY and by 2.8% QoQ

Dividends

What is SYK's dividend history
Dividend details
DPS
$3.15
Dividend yield
0.95%
Payout ratio
35.6%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 95% greater than the total liabilities
The current ratio has grown by 8% since the previous quarter
The total assets has increased by 7% year-on-year
SYK's debt is 33% less than its equity
The debt to equity has contracted by 13% YoY and by 4.3% from the previous quarter
SYK's equity is up by 13% year-on-year and by 3.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.